Biomarin Pharmaceutical Inc (BMRN)
Return on total capital
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 689,643 | 850,797 | 685,960 | 554,102 | 407,044 | 315,083 | 253,938 | 205,304 | 165,948 | 123,275 | 87,420 | 164,953 | 116,157 | 71,092 | 50,355 | -60,606 | -32,721 | -42,050 | -94,770 | -13,535 |
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 6,056,710 | 6,027,110 | 5,793,460 | 5,657,990 | 5,413,400 | 5,286,300 | 5,073,820 | 4,951,550 | 4,896,900 | 4,782,830 | 4,659,040 | 4,603,160 | 4,568,510 | 4,504,810 | 4,391,320 | 4,270,740 | 4,266,150 | 4,241,570 | 4,162,010 | 4,106,000 |
| Return on total capital | 11.39% | 14.12% | 11.84% | 9.79% | 7.52% | 5.96% | 5.00% | 4.15% | 3.39% | 2.58% | 1.88% | 3.58% | 2.54% | 1.58% | 1.15% | -1.42% | -0.77% | -0.99% | -2.28% | -0.33% |
September 30, 2025 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $689,643K ÷ ($—K + $6,056,710K)
= 11.39%
Peer comparison
Sep 30, 2025
Company name
Symbol
Return on total capital
Biomarin Pharmaceutical Inc
BMRN
11.39%
Arrowhead Pharmaceuticals Inc
ARWR
17.83%
Regeneron Pharmaceuticals Inc
REGN
16.76%